COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...
top of page
China released the 2022 NDRL list, Chinese pharma benefited from the list
China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...
WHO granted EUL to Covaxin; acclaims easy storage requirement
WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...
Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
Novartis entered a strategic collaboration with BeiGene to license tislelizumab; to market in major markets outside China, including...
Bayer submitted vericiguat for market authorization in China
Bayer has announced that it has submitted an application requesting the approval of vericiguat in China for the treatment of chronic...
Bayer’s Xofigo received approval for prostate cancer in China
Bayer has announced that the Chinese National Medical Products Administration (NMPA) approved Xofigo (radium-223 dichloride) for treating...
Merck’s Keytruda received one more indication and dosage form approval in Japan
Merck has announced that it has received the approval of its anti-PD-1 therapy, Keytruda (pembrolizumab) for radically unresectable,...
AZ received one more approval in Japan, received approval of Imfinzi for SCLC
The Japanese Ministry of Health, Labor, and Welfare approved AstraZeneca’s Imfinzi (durvalumab) for treating patients with...
JAPAN HEALTHCARE SYSTEM
INTRODUCTION Japan has a population of 126 million, nearly twice the size of the UK population. Japan is the third-largest economy. The...
China’s National Medicinal Products Administration approved Gilead’s Truvada
Gilead has announced that China’s National Medicinal Products Administration has approved Truvada (emtricitabine 200mg/tenofovir...
Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia
Approval of Dayvigo in Japan On July 6th, 2020, Eisai announced that it had launched Dayvigo (lemborexant) in Japan for insomnia. The...
Merck’s Keytruda approved in China for esophageal squamous cell carcinoma
Merck has announced that it has received approval from the Chinese National Medical Products Administration (NMPA) in China for Keytruda...
GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial
GSK has announced that Clover Biopharmaceuticals initiated the Phase 1 trial of COVID-19 vaccine SCB-2019. The vaccine was given in...
May witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore
In Singapore, the Health Sciences Authority has approved three new products in May. Ajovy approved for migraine in adults Tuksya approved...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19...
bottom of page